- Introduced
- In committeeHealth, Education, Labor, and Pensions
- Passed the Senate (not yet)
- Passed the House (not yet)
- Law (not yet)
What it would change
About this text
Text: Introduced The text as a member of Congress first filed it. Most bills never get further than this., (the only version so far)
This bill would change existing law, but we couldn't automatically match its changes to the Code.
Its own words follow, each change we couldn't place marked where it stands.
1 change we couldn't place in the Code
- § 502 In the bill’s text
Sec. 1. Short title This Act may be cited as the End Prescription Drug Ads Now Act.
Sec. 2. Prohibition on direct-to-consumer drug advertising of drugs
(a) In general Section 502 the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352) is amended by adding at the end the following:
(hh)
(1) If it is a drug approved under section 505 or licensed under section 351 of the Public Health Service Act, and subject to section 503(b)(1), and the holder of the approved application under section 505 or of the license under such section 351 has conducted direct-to-consumer advertising of the drug within the most recent 30-day period.
(2) For purposes of this paragraph, the term “direct-to-consumer advertising”, with respect to a drug subject to section 503(b)(1), means any promotional communication targeting consumers, including through television, radio, print media, digital platforms, and social media, for purposes of marketing such a drug.
.
We couldn't place this change in the Code: we can't yet read how this change is worded.
(b) Effective date The amendment made by subsection (a) shall take effect 30 days after the date of enactment of this Act, and shall apply with respect to any drug approved under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) or licensed under section 351 of the Public Health Service Act (42 U.S.C. 262), regardless of when the drug was approved or licensed.